ArticleMedical oncology (Northwood, London, England)2017

EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.

Timothy D Clay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.